drugset / Trial / NCT04075604
A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized multi-arm study evaluating the safety and efficacy of palbociclib and anastrozole with or without nivolumab in participants with ER+/HER2- breast cancer
Timeline
- Start
- 2019-10-18
- Primary completion
- 2021-07-27
- Completion
- 2021-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |
| Subject | Palbociclib | Small molecule | — | — |